The British Journal of Cardiology

This site is intended for UK healthcare professionals

 
BJC_tv_logo_white
Sign in
Sponsorship statement:
This educational activity was funded by Novartis Pharmaceuticals Ltd; however, the British Journal of Cardiology retained full editorial control, including the formulation of the agenda, contents and selection of speakers. This video is broadcast in association with the British Journal of Cardiology; the media partner is GPnotebook, and GPnotebook has had no input into the content of the activity.
novartis-logo-transparent

Harmonising the guidelines: making sense of lipid treatment advice

23 July 2024
Watch Terry McCormack and Rani Khatib discuss the updates to lipid management guidelines to reduce the risk of cardiovascular disease and implications for clinical practice. They will provide an overview of which patients should be treated, outline the current lipid-lowering targets and introduce the range of suitable treatments.

Professor Terry McCormack Professor of Primary Care Cardiovascular Medicine, Hull York Medical School
Dr Rani Khatib Consultant Pharmacist in Cardiology & Cardiovascular Research, Leeds Teaching Hospitals NHS Trust

PODCAST SUMMARY: LISTEN HERE

Summary of national guidance for lipid management for primary and secondary prevention of cardiovascular disease

Categories

Tags

blank

ESC Congress 2024 highlights – A UK perspective: What’s new in the latest ESC guideline update?

  • Paul Foley, Terry McCormack

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

blank

ESC Congress 2024 highlights – A UK perspective: New evidence on cardiovascular medical care

  • Sarah Birkhoelzer, Aaron Henry

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

blank

© 2024 Medinews Cardiology Ltd, a wholly-owned subsidiary of OmniaMed Communications Ltd   |   Privacy & cookies policy   |   Terms & conditions

 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.